LABS ETF — Holdings & Analysis

For informational purposes only. Not financial advice.

Quick Answer

Direxion Daily S&P Biotech Bear 1X ETF (LABS), managed by Direxion, is a equity ETF. inception 2015.

Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis

Direxion Daily S&P Biotech Bear 1X ETF (LABS), managed by Direxion, is a equity ETF. inception 2015.

ETF Overview

Direxion Daily S&P Biotech Bear 1X ETF provides exposure to the equity market. Direxion Daily S&P Biotech Bear 1X ETF invests across equity markets, providing investors with diversified exposure to this asset class through a single, exchange-traded vehicle. As an exchange-traded fund, it offers the benefits of intraday liquidity, transparent holdings, and generally lower costs compared to traditional mutual fund structures.

Risk Metrics

As with all ETFs, the fund is subject to market risk and its value will fluctuate with market conditions. Past performance does not guarantee future results. The fund's investment objectives, risks, charges, and expenses carefully before investing may be worth researching.

iShares Russell 2000 ETF (IWM) — 0.19% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
iShares MSCI Emerging Markets ETF (EEM) — 0.72% expense ratio
iShares MSCI EAFE ETF (EFA) — 0.32% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
State Street SPDR S&P 500 ETF (SPY) — 0.09% expense ratio

Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
Direxion World Without Waste ETF (WWOW) (Equity) — 0.50% expense ratio
Direxion Daily AMD Bull 2X ETF (AMUU) (Equity) — 1.16% expense ratio
Direxion Russell Small Over Large Cap ETF (RWSL) (Equity) — 0.59% expense ratio
Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio

Questions & Answers

How long has LABS been around?

Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions. It is managed by Direxion.

Is LABS a good investment?

Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.

Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.

Who manages LABS?

Direxion Daily S&P Biotech Bear 1X ETF is managed by Direxion. The fund manager is responsible for portfolio construction, rebalancing, and ensuring the ETF tracks its investment objective. Direxion provides institutional-grade management and oversight for the fund's investors.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

Written by machine, not reviewed page by page. Editorial oversight is systemic: the rules and the sources are checked, individual pages are not.